133 related articles for article (PubMed ID: 3524833)
1. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Greco A; Prestridge K; Johnson R
Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833
[No Abstract] [Full Text] [Related]
2. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
[No Abstract] [Full Text] [Related]
3. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
[No Abstract] [Full Text] [Related]
4. Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
Maroun JA; Maksymiuk A; Eisenhauer E; Stewart DJ; Young V; Pater J
Cancer Treat Rep; 1986 Nov; 70(11):1327-8. PubMed ID: 3021326
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E
Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of acivicin in patients with advanced cancer.
Sridhar KS; Ohnuma T; Chahinian AP; Holland JF
Cancer Treat Rep; 1983; 67(7-8):701-3. PubMed ID: 6871885
[No Abstract] [Full Text] [Related]
7. Phase II trial of acivicin in malignant mesothelioma.
Falkson G; Vorobiof DA; Simson IW; Borden EC
Cancer Treat Rep; 1987 May; 71(5):545-6. PubMed ID: 3567981
[No Abstract] [Full Text] [Related]
8. Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
McGuire WP; Blessing JA; DiSaia PJ; Buchsbaum HJ
Invest New Drugs; 1986; 4(1):49-52. PubMed ID: 3700040
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
[No Abstract] [Full Text] [Related]
10. Phase II trial of acivicin in advanced metastatic breast cancer.
Fleishman G; Yap HY; Murphy WK; Bodey G
Cancer Treat Rep; 1983 Sep; 67(9):843-4. PubMed ID: 6883364
[No Abstract] [Full Text] [Related]
11. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
[No Abstract] [Full Text] [Related]
12. Phase I-II trial of acivicin in adult acute leukemia.
Powell BL; Craig JB; Capizzi RL; Richards F
Invest New Drugs; 1988 Apr; 6(1):41-4. PubMed ID: 3165971
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada Clinical Trials Group Study.
Eisenhauer EA; Maroun JA; Fields AL; Walde PL
Invest New Drugs; 1987 Dec; 5(4):375-8. PubMed ID: 3436743
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Fiore J; Kemeny N; Raymond V; Young C
Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
[No Abstract] [Full Text] [Related]
15. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY
Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371
[TBL] [Abstract][Full Text] [Related]
16. Phase II evaluation of pyrazofurin in patients with carcinoma of the lung.
Gralla RJ; Currie VE; Wittes RE; Golbey RB; Young CW
Cancer Treat Rep; 1978 Mar; 62(3):451-2. PubMed ID: 348315
[No Abstract] [Full Text] [Related]
17. Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group B.
Green MR; Vosika G; Propert KJ; Ware JH; Comis R
Cancer Treat Rep; 1986 Apr; 70(4):539-40. PubMed ID: 3698052
[No Abstract] [Full Text] [Related]
18. Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial.
Hochster HS; Green MD; Blum RH; Wernz JC; Speyer JL; Muggia FM
Invest New Drugs; 1986; 4(3):275-8. PubMed ID: 3469171
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.
Myers JW; Von Hoff DD; Clark GM; Coltman CA
Cancer Treat Rep; 1984 Jun; 68(6):927-8. PubMed ID: 6329511
[No Abstract] [Full Text] [Related]
20. Phase II evaluation of pyrazofurin in patients with metastatic sarcoma.
Gralla RJ; Sordillo PP; Magill GB
Cancer Treat Rep; 1978 Oct; 62(10):1573-4. PubMed ID: 361228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
